Stocks · News reference

IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain

Aug 17, 2026, 5:54 PMVandana Singh

IM Cannabis enters a definitive deal to sell its subsidiary to Slil, aiming to boost equity and focus on Israeli assets.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 18, 2026, 9:06 PMBenzinga Insights
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2 earnings came
Read original at benzinga
AHG APUS CRIS HCWB IMCC
BenzingaAug 18, 2026, 9:04 PMBenzinga Newsdesk
IM Cannabis To Complete 30-To-1 Share Consolidation On Or Before September 15, 2026
IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has
Read original at benzinga
IMCC
BenzingaAug 17, 2026, 1:22 PMBenzinga Newsdesk
IM Cannabis shares are trading lower after the company announced that it's selling some subsidiary companies excluding Israeli assets to Slil.com for approximately C$3 million.
Read original at benzinga
IMCC